Attach importance to the clinical value of FMT in the treatment of hematologic diseasesWU De-pei, ZHAO Ye265-267
Best donor selection in allogeneic hematopoietic stem cell transplantation settings: should human leukocyte antigen-matched sibling donor always be selected first?WU Wei-bing, CHANG Ying-jun272-278
Evidence-based evaluation of prognostic systems in chronic myelomonocytic leukemiaXU Ruo-hao, DU Xin296-300
Eltrombopag combing with intensive immunosuppressive therapy for elderly severe aplastic anemia: clinical analysis of 35 casesCHAI Xing-xing, LI Rui-xin, DU Xiao-peng, HE Yao, LIU Xiao-qing, CHENG Lang, LONG Qi-qiang, ZHUANG Wan-chuan, YANG Yan, LIN Sheng-yun, JIA Jin-song, HE Guang-sheng, LI Jian-yong301-305
Clinical characteristics and therapeutic efficacy of NRAS mutation in adults with cytogenetically acute myeloid leukemiaSHENG Ye-ping, HUA Hai-ying, CHAO Hong-ying, ZHU Wen-yan, WANG Zhi-qing, ZHANG Yan, ZHOU Ye306-309,320
Analysis of the coincidence rate between biopsy and postoperative pathology of gastrointestinal neuroendocrine tumor and analysis of the significanceLI Jing, GAO Zhu-qing, ZHANG Qian, LI Peng310-314